Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 840.00 839.00 840.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 620.5 -70.6 3.9 215.4 3,261

Btg Share Discussion Threads

Showing 5901 to 5917 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
11/11/2018
18:11
What to compare on Tuesday. 4 October 2018 | 09:45am StockMarketWire.com - Healthcare company BTG guided product sales higher Thursday after including its varicose vein treatment Varithena in its oncology and vascular portfolio. The company said it expected product sales for the combined portfolio to grow by 15%-to-17% this year, up from its previous forecast of 13%-to-15%. In pharmaceuticals, following a good first half, BTG said it expected full-year sales to be around the upper end of the guidance range of flat-to-single digit decline. A better-than-expected first-half performance in pharmaceuticals was driven by DigiFab and Voraxaze, and a good performance from CroFab, BTG said. First-half product sales growth was driven by 'good' performance in Interventional Medicine led by strong growth in radiotherapy treatment TheraSphere and the cryoablation products, the company said. Varithena was expected to become profitable during the 2019/20 financial year with sales expected to peak in the high tens of millions of dollars. Varithena sales would be included within the Vascular product sales line going forwards, BTG said. The company also announced that Chairman Garry Watts was set to retire. At 9:45am: [LON:BTG] BTG PLC share price was +31p at 590.5p Story provided by StockMarketWire.com
bargainbob
11/11/2018
18:06
Catch me up. What's happening (or not?)
waterloo01
11/11/2018
17:08
Yes , whether we will know who was eyeing us up is another thing .
bargainbob
11/11/2018
17:06
7.01 am Tuesday.....the moment of truth!
fhmktg
10/11/2018
20:48
Just highest riser of the day : reason momentum continues. I have a feeling what's happening , as the timeline fits . Good luck all.
bargainbob
10/11/2018
19:15
Bargain what was the article in daily mail focusing on?
dp1umb
10/11/2018
14:14
Mention in mail , momentum continues .
bargainbob
09/11/2018
16:34
Hope I am wrong but it n the past this shares has risen before results then slipped after. Here's hoping I am wrong as a LTH.
bill hunt
09/11/2018
16:23
No need to be careful he a investment fud.
bargainbob
09/11/2018
07:26
Good news day for Pharma , back to growth again .
bargainbob
07/11/2018
19:44
More good trials results.....building nicely towards the results.Hopefully no serious write-downs in the results.
fhmktg
06/11/2018
12:50
it got new legs . glad i did not short on TW 's tip
cannyshoveyergrannyoffthebus
06/11/2018
10:28
It’s not all doom and gloom like some posters would have us believe!
dp1umb
06/11/2018
08:10
New version of Ekos comes to Europe...spread the news!
fhmktg
01/11/2018
12:11
no just proving Cokney trader wrong imho. who has left the building since he was accussed of being Tom W.
cannyshoveyergrannyoffthebus
01/11/2018
11:32
Is this the traditional run up towards the results, or an early Santa run?Long way to go, but very welcome!
fhmktg
29/10/2018
18:15
Wow great bounce back.
bargainbob
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
BTG
Btg
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201205 13:13:46